Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley

July 16, 2026 07:09 AM EDT Deals Lil­ly bets $2.8B up­front on psy­che­delics in deal to buy AtaiBeck­ley Reynald Castaneda Deputy Editor Eli Lil­ly said on Thurs­day it will buy psy­che­del­ic drug de­vel­op­er AtaiBeck­ley for $2.8 bil­lion up­front, in a move that fur­ther spot­lights big phar­ma’s in­creas­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER